Regenerex Pharma, Inc. Quality Score

RGPX

⊜ Compare

Quality15

Weak across most dimensions. This doesn't mean avoid, but the burden of proof is on the bull case.

Broad-market heuristics · Not a buy/sell signal

Valuation and growth

Growth

Revenue Growth

0/100

-31.9%

Below 2%, essentially flat

Business Quality & Capital Allocation

Share Dilution

0/100

121.7%

Heavy dilution above 5%

Margin Trend

100/100

+506.9pp

Expanded 3+pp, strong improvement

Capital Structure

0/100

$3M

Positive debt with no FCF to service it

2020

$5460

$291723

2021

$6902

$374271

TTM

$11659

$3.00M

CashDebt

Return on Capital

0/100

-10.3%

Below 8%, may not cover cost of capital

Customize WeightsPremiumAdjust metric weights to match your investment style.Upgrade

SourceQuality score computed from the 10-Q filed 17 Nov 2025, covering the period ending 30 Sept 2025, as reported to the SEC. Data last refreshed 12 Oct 2026. How this is calculated.

Fiscal year ends Dec. Sector medians are approximate S&P 500 benchmarks and update periodically. Checks use broad-market heuristics, so sector norms may differ, and the valuation checks are more cyclical than the quality checks.

Peers

Pharmaceutical Preparations · Pick stocks to compare with RGPX

CompareIntrinsic value

TLPHTalphera Inc.

$1.05+0.96%10

TCRTAlaunos Therapeutics Inc.

$1.80-3.23%10

ASBPAspire Biopharma Holdings Inc.

$7.27-0.41%20

GNLXGenelux Corp.

$1.96+2.08%10

ADTXAditxt Inc.

$0.00+33.33%20

CELZCreative Medical Technology Holdings Inc.

$0.65-3.21%10

CDIOCardio Diagnostics Holdings Inc.

$1.65+2.81%30

NTRRNeutra Corp

$0.00+0.00%40

Spot a number that looks wrong? Check it in RGPX's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing RGPX

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.